PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rreb1
|
ENSMUSG00000039087.18 | Rreb1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Rreb1 | mm39_v1_chr13_+_38041910_38041968 | -0.42 | 2.7e-04 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_149330371 | 5.12 |
ENSMUST00000066337.13
ENSMUST00000112715.2 |
Alas2
|
aminolevulinic acid synthase 2, erythroid |
chr16_-_19525122 | 4.76 |
ENSMUST00000081880.7
|
Lamp3
|
lysosomal-associated membrane protein 3 |
chr9_-_109678685 | 3.88 |
ENSMUST00000112022.5
|
Camp
|
cathelicidin antimicrobial peptide |
chr7_+_24596806 | 3.66 |
ENSMUST00000003469.8
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
chr7_+_86895851 | 3.66 |
ENSMUST00000032781.14
|
Nox4
|
NADPH oxidase 4 |
chr18_-_38131766 | 3.43 |
ENSMUST00000236588.2
ENSMUST00000237272.2 ENSMUST00000236134.2 |
Arap3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr6_-_5193757 | 3.38 |
ENSMUST00000177159.9
ENSMUST00000176945.2 |
Pon1
|
paraoxonase 1 |
chr7_+_86895996 | 3.37 |
ENSMUST00000068829.13
|
Nox4
|
NADPH oxidase 4 |
chr6_-_5193816 | 3.23 |
ENSMUST00000002663.12
|
Pon1
|
paraoxonase 1 |
chr9_+_88209250 | 3.03 |
ENSMUST00000034992.8
|
Nt5e
|
5' nucleotidase, ecto |
chr7_-_48497771 | 2.96 |
ENSMUST00000032658.14
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr8_-_3744167 | 2.95 |
ENSMUST00000005678.6
|
Fcer2a
|
Fc receptor, IgE, low affinity II, alpha polypeptide |
chr1_-_192955407 | 2.89 |
ENSMUST00000009777.4
|
G0s2
|
G0/G1 switch gene 2 |
chr11_-_106205320 | 2.79 |
ENSMUST00000167143.2
|
Cd79b
|
CD79B antigen |
chr9_-_48252176 | 2.62 |
ENSMUST00000034527.14
|
Nxpe2
|
neurexophilin and PC-esterase domain family, member 2 |
chr6_+_87755046 | 2.55 |
ENSMUST00000032133.5
|
Gp9
|
glycoprotein 9 (platelet) |
chr3_-_90373165 | 2.41 |
ENSMUST00000029540.13
|
Npr1
|
natriuretic peptide receptor 1 |
chr4_+_97665992 | 2.34 |
ENSMUST00000107062.9
ENSMUST00000052018.12 ENSMUST00000107057.8 |
Nfia
|
nuclear factor I/A |
chr11_+_101932328 | 2.29 |
ENSMUST00000123895.8
ENSMUST00000017453.12 ENSMUST00000107163.9 ENSMUST00000107164.3 |
Cd300lg
|
CD300 molecule like family member G |
chr6_+_17307272 | 2.28 |
ENSMUST00000115454.2
|
Cav1
|
caveolin 1, caveolae protein |
chr12_-_81015479 | 2.25 |
ENSMUST00000218162.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr12_+_112586465 | 2.22 |
ENSMUST00000021726.8
|
Adssl1
|
adenylosuccinate synthetase like 1 |
chr6_+_17307038 | 2.19 |
ENSMUST00000123439.8
|
Cav1
|
caveolin 1, caveolae protein |
chr15_+_44320918 | 2.11 |
ENSMUST00000038336.12
ENSMUST00000166957.2 ENSMUST00000209244.2 |
Pkhd1l1
|
polycystic kidney and hepatic disease 1-like 1 |
chr8_+_15107646 | 2.10 |
ENSMUST00000033842.4
|
Myom2
|
myomesin 2 |
chr17_-_32074754 | 2.04 |
ENSMUST00000024839.6
|
Sik1
|
salt inducible kinase 1 |
chr5_+_122239030 | 2.04 |
ENSMUST00000139213.8
ENSMUST00000111751.8 ENSMUST00000155612.8 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr18_+_80298441 | 2.04 |
ENSMUST00000123750.8
|
Slc66a2
|
solute carrier family 66 member 2 |
chr19_+_21755689 | 2.03 |
ENSMUST00000096194.9
ENSMUST00000025663.8 |
Cemip2
|
cell migration inducing hyaluronidase 2 |
chr11_-_70120503 | 2.02 |
ENSMUST00000153449.2
ENSMUST00000000326.12 |
Bcl6b
|
B cell CLL/lymphoma 6, member B |
chr4_+_43727180 | 2.01 |
ENSMUST00000095109.5
|
Hrct1
|
histidine rich carboxyl terminus 1 |
chr4_+_97665843 | 1.99 |
ENSMUST00000075448.13
ENSMUST00000092532.13 |
Nfia
|
nuclear factor I/A |
chr16_-_31984272 | 1.99 |
ENSMUST00000231836.2
ENSMUST00000115163.4 ENSMUST00000144345.2 ENSMUST00000143682.8 ENSMUST00000115165.10 ENSMUST00000099991.11 ENSMUST00000130410.8 |
Nrros
|
negative regulator of reactive oxygen species |
chr1_-_84262274 | 1.98 |
ENSMUST00000177458.2
ENSMUST00000168574.9 |
Pid1
|
phosphotyrosine interaction domain containing 1 |
chr4_+_114916703 | 1.96 |
ENSMUST00000162489.2
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr7_-_44180700 | 1.95 |
ENSMUST00000205506.2
|
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr5_+_122239007 | 1.95 |
ENSMUST00000014080.13
ENSMUST00000111750.8 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr12_+_112586501 | 1.94 |
ENSMUST00000180015.9
|
Adssl1
|
adenylosuccinate synthetase like 1 |
chr2_+_158148413 | 1.92 |
ENSMUST00000109491.8
ENSMUST00000016168.9 |
Lbp
|
lipopolysaccharide binding protein |
chr16_+_22713593 | 1.92 |
ENSMUST00000232674.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr12_-_112766266 | 1.89 |
ENSMUST00000239525.1
|
Ahnak2
|
AHNAK nucleoprotein 2 |
chr1_-_184543367 | 1.85 |
ENSMUST00000048462.13
ENSMUST00000110992.9 |
Mtarc1
|
mitochondrial amidoxime reducing component 1 |
chr9_+_21231994 | 1.82 |
ENSMUST00000217461.2
|
Slc44a2
|
solute carrier family 44, member 2 |
chr8_+_72889073 | 1.82 |
ENSMUST00000003575.11
|
Tpm4
|
tropomyosin 4 |
chr17_+_35296056 | 1.78 |
ENSMUST00000172959.2
|
Ly6g6e
|
lymphocyte antigen 6 complex, locus G6E |
chr17_+_44263890 | 1.76 |
ENSMUST00000177857.9
ENSMUST00000044792.6 |
Rcan2
|
regulator of calcineurin 2 |
chr4_-_131776368 | 1.74 |
ENSMUST00000105981.9
ENSMUST00000084253.10 ENSMUST00000141291.3 |
Epb41
|
erythrocyte membrane protein band 4.1 |
chr13_-_119545479 | 1.73 |
ENSMUST00000223268.2
|
Nnt
|
nicotinamide nucleotide transhydrogenase |
chr6_+_17306414 | 1.68 |
ENSMUST00000150901.2
|
Cav1
|
caveolin 1, caveolae protein |
chr6_+_17306379 | 1.67 |
ENSMUST00000115455.3
|
Cav1
|
caveolin 1, caveolae protein |
chr2_+_103788321 | 1.67 |
ENSMUST00000156813.8
ENSMUST00000170926.8 |
Lmo2
|
LIM domain only 2 |
chr1_-_162687254 | 1.66 |
ENSMUST00000131058.8
|
Fmo1
|
flavin containing monooxygenase 1 |
chr7_+_25327028 | 1.66 |
ENSMUST00000076034.8
|
B3gnt8
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 |
chr12_-_16639756 | 1.65 |
ENSMUST00000222989.2
ENSMUST00000067124.6 ENSMUST00000221230.2 |
Lpin1
|
lipin 1 |
chr6_+_72333209 | 1.65 |
ENSMUST00000206531.2
|
Tmem150a
|
transmembrane protein 150A |
chr6_+_65648574 | 1.63 |
ENSMUST00000054351.6
|
Ndnf
|
neuron-derived neurotrophic factor |
chr5_-_147662798 | 1.62 |
ENSMUST00000110529.6
ENSMUST00000031653.12 |
Flt1
|
FMS-like tyrosine kinase 1 |
chr6_+_72526236 | 1.62 |
ENSMUST00000114071.8
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr15_-_102165884 | 1.61 |
ENSMUST00000043172.15
|
Rarg
|
retinoic acid receptor, gamma |
chr8_+_105810380 | 1.60 |
ENSMUST00000093221.13
ENSMUST00000074403.13 |
Ces3b
|
carboxylesterase 3B |
chrX_+_163052367 | 1.60 |
ENSMUST00000145412.8
ENSMUST00000033749.9 |
Pir
|
pirin |
chr12_+_102249375 | 1.59 |
ENSMUST00000101114.11
ENSMUST00000150795.8 |
Rin3
|
Ras and Rab interactor 3 |
chr13_+_52750883 | 1.58 |
ENSMUST00000055087.7
|
Syk
|
spleen tyrosine kinase |
chr7_-_140535899 | 1.58 |
ENSMUST00000081649.10
|
Ifitm2
|
interferon induced transmembrane protein 2 |
chr7_-_84254973 | 1.57 |
ENSMUST00000032865.17
|
Fah
|
fumarylacetoacetate hydrolase |
chr5_+_122348140 | 1.57 |
ENSMUST00000196187.5
ENSMUST00000100747.3 |
Hvcn1
|
hydrogen voltage-gated channel 1 |
chr13_-_119545520 | 1.56 |
ENSMUST00000069902.13
ENSMUST00000099149.10 ENSMUST00000109204.8 |
Nnt
|
nicotinamide nucleotide transhydrogenase |
chr2_+_90948481 | 1.53 |
ENSMUST00000137942.8
ENSMUST00000111430.10 ENSMUST00000169776.2 |
Mybpc3
|
myosin binding protein C, cardiac |
chr3_+_10077608 | 1.48 |
ENSMUST00000029046.9
|
Fabp5
|
fatty acid binding protein 5, epidermal |
chr5_+_120649233 | 1.46 |
ENSMUST00000068326.14
ENSMUST00000111890.9 ENSMUST00000076051.12 ENSMUST00000147496.2 |
Slc8b1
|
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
chr10_-_24803336 | 1.44 |
ENSMUST00000020161.10
|
Arg1
|
arginase, liver |
chr7_+_140547134 | 1.44 |
ENSMUST00000106042.9
|
Ifitm1
|
interferon induced transmembrane protein 1 |
chr6_+_72526414 | 1.43 |
ENSMUST00000155705.8
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr7_-_140535828 | 1.43 |
ENSMUST00000211129.2
|
Gm45717
|
predicted gene 45717 |
chr4_-_63073028 | 1.41 |
ENSMUST00000142901.2
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr4_-_58206596 | 1.41 |
ENSMUST00000042850.9
|
Svep1
|
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr9_-_44255456 | 1.41 |
ENSMUST00000077353.15
|
Hmbs
|
hydroxymethylbilane synthase |
chr5_-_108822619 | 1.41 |
ENSMUST00000119270.2
ENSMUST00000163328.8 ENSMUST00000136227.2 |
Slc26a1
|
solute carrier family 26 (sulfate transporter), member 1 |
chr18_-_64622092 | 1.40 |
ENSMUST00000235766.3
ENSMUST00000025484.9 ENSMUST00000237502.2 ENSMUST00000236586.3 |
Fech
|
ferrochelatase |
chr6_+_72526635 | 1.40 |
ENSMUST00000134809.8
|
Capg
|
capping protein (actin filament), gelsolin-like |
chr14_+_75368939 | 1.39 |
ENSMUST00000125833.8
ENSMUST00000124499.8 |
Lcp1
|
lymphocyte cytosolic protein 1 |
chr3_-_137945419 | 1.39 |
ENSMUST00000199804.3
ENSMUST00000185122.8 ENSMUST00000183783.8 |
4930579F01Rik
0610031O16Rik
|
RIKEN cDNA 4930579F01 gene RIKEN cDNA 0610031O16 gene |
chr2_+_180861804 | 1.38 |
ENSMUST00000050026.7
ENSMUST00000108835.2 |
Fndc11
|
fibronectin type III domain containing 11 |
chr14_-_67246282 | 1.37 |
ENSMUST00000111115.8
ENSMUST00000022634.9 |
Bnip3l
|
BCL2/adenovirus E1B interacting protein 3-like |
chr15_-_102165740 | 1.36 |
ENSMUST00000135466.2
|
Rarg
|
retinoic acid receptor, gamma |
chr5_-_103803578 | 1.36 |
ENSMUST00000120688.6
ENSMUST00000134926.8 ENSMUST00000120108.8 |
1700016H13Rik
|
RIKEN cDNA 1700016H13 gene |
chr1_-_84262144 | 1.35 |
ENSMUST00000176720.2
|
Pid1
|
phosphotyrosine interaction domain containing 1 |
chr1_+_87603952 | 1.34 |
ENSMUST00000170300.8
ENSMUST00000167032.2 |
Inpp5d
|
inositol polyphosphate-5-phosphatase D |
chr13_-_76453191 | 1.33 |
ENSMUST00000208418.2
|
Fam81b
|
family with sequence similarity 81, member B |
chr18_+_42186757 | 1.33 |
ENSMUST00000074679.4
|
Sh3rf2
|
SH3 domain containing ring finger 2 |
chr2_-_45003270 | 1.33 |
ENSMUST00000202935.4
ENSMUST00000068415.11 ENSMUST00000127520.8 |
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr9_+_74769166 | 1.33 |
ENSMUST00000056006.11
|
Onecut1
|
one cut domain, family member 1 |
chr17_-_28298721 | 1.33 |
ENSMUST00000233898.2
ENSMUST00000232798.2 |
Tcp11
|
t-complex protein 11 |
chr12_-_16639721 | 1.31 |
ENSMUST00000221146.2
|
Lpin1
|
lipin 1 |
chr17_+_34362281 | 1.30 |
ENSMUST00000236519.2
|
H2-DMb2
|
histocompatibility 2, class II, locus Mb2 |
chr4_-_3938352 | 1.30 |
ENSMUST00000003369.10
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr10_+_86136236 | 1.30 |
ENSMUST00000020234.14
|
Timp3
|
tissue inhibitor of metalloproteinase 3 |
chr19_-_44017637 | 1.29 |
ENSMUST00000026211.10
ENSMUST00000211830.2 |
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr2_+_122607297 | 1.29 |
ENSMUST00000124460.2
ENSMUST00000147475.2 |
Sqor
|
sulfide quinone oxidoreductase |
chr18_-_32271224 | 1.28 |
ENSMUST00000234657.2
ENSMUST00000234386.2 ENSMUST00000234651.2 |
Proc
|
protein C |
chr9_+_62248611 | 1.28 |
ENSMUST00000085519.13
|
Anp32a
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
chrX_-_71318353 | 1.25 |
ENSMUST00000064780.4
|
Gabre
|
gamma-aminobutyric acid (GABA) A receptor, subunit epsilon |
chr18_+_64473091 | 1.24 |
ENSMUST00000175965.10
|
Onecut2
|
one cut domain, family member 2 |
chr18_+_42186713 | 1.23 |
ENSMUST00000072008.11
|
Sh3rf2
|
SH3 domain containing ring finger 2 |
chr1_-_71454041 | 1.22 |
ENSMUST00000087268.7
|
Abca12
|
ATP-binding cassette, sub-family A (ABC1), member 12 |
chr9_+_98305014 | 1.22 |
ENSMUST00000052068.11
|
Rbp1
|
retinol binding protein 1, cellular |
chr3_-_88286006 | 1.21 |
ENSMUST00000098956.3
|
Bglap2
|
bone gamma-carboxyglutamate protein 2 |
chr6_+_127864543 | 1.19 |
ENSMUST00000032501.6
|
Tspan11
|
tetraspanin 11 |
chr15_-_55770118 | 1.18 |
ENSMUST00000110200.3
|
Sntb1
|
syntrophin, basic 1 |
chr13_-_55574596 | 1.18 |
ENSMUST00000021948.15
|
F12
|
coagulation factor XII (Hageman factor) |
chr12_+_112611322 | 1.17 |
ENSMUST00000109755.5
|
Siva1
|
SIVA1, apoptosis-inducing factor |
chr17_-_26727437 | 1.17 |
ENSMUST00000236661.2
ENSMUST00000025025.7 |
Dusp1
|
dual specificity phosphatase 1 |
chr9_+_54606144 | 1.16 |
ENSMUST00000120452.8
|
Dnaja4
|
DnaJ heat shock protein family (Hsp40) member A4 |
chr14_+_69846927 | 1.15 |
ENSMUST00000100420.4
|
Loxl2
|
lysyl oxidase-like 2 |
chr2_+_155223728 | 1.15 |
ENSMUST00000043237.14
ENSMUST00000174685.8 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr5_+_102992873 | 1.15 |
ENSMUST00000070000.6
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr2_+_122607157 | 1.15 |
ENSMUST00000005953.11
|
Sqor
|
sulfide quinone oxidoreductase |
chr10_+_128030500 | 1.15 |
ENSMUST00000123291.2
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr4_+_62204678 | 1.15 |
ENSMUST00000084530.9
|
Slc31a2
|
solute carrier family 31, member 2 |
chr4_+_155924181 | 1.15 |
ENSMUST00000030947.4
|
Mxra8
|
matrix-remodelling associated 8 |
chr11_+_95304903 | 1.14 |
ENSMUST00000107724.9
ENSMUST00000150884.8 ENSMUST00000107722.8 ENSMUST00000127713.2 |
Spop
|
speckle-type BTB/POZ protein |
chr13_-_93810808 | 1.14 |
ENSMUST00000015941.8
|
Bhmt2
|
betaine-homocysteine methyltransferase 2 |
chr10_+_77905136 | 1.14 |
ENSMUST00000105393.3
|
Icosl
|
icos ligand |
chr17_+_29587930 | 1.14 |
ENSMUST00000137644.3
|
Fgd2
|
FYVE, RhoGEF and PH domain containing 2 |
chr7_+_16576978 | 1.14 |
ENSMUST00000086104.6
|
Prkd2
|
protein kinase D2 |
chr7_+_16576821 | 1.14 |
ENSMUST00000168093.9
|
Prkd2
|
protein kinase D2 |
chr19_+_27194411 | 1.13 |
ENSMUST00000164746.8
ENSMUST00000172302.8 |
Vldlr
|
very low density lipoprotein receptor |
chr5_-_34345014 | 1.13 |
ENSMUST00000042701.13
ENSMUST00000119171.2 |
Mxd4
|
Max dimerization protein 4 |
chr13_-_92712671 | 1.13 |
ENSMUST00000050658.6
|
Spz1
|
spermatogenic leucine zipper 1 |
chr6_+_29529275 | 1.13 |
ENSMUST00000163511.7
|
Irf5
|
interferon regulatory factor 5 |
chr13_-_55574582 | 1.13 |
ENSMUST00000170921.2
|
F12
|
coagulation factor XII (Hageman factor) |
chr8_+_105951777 | 1.12 |
ENSMUST00000034361.10
|
D230025D16Rik
|
RIKEN cDNA D230025D16 gene |
chr19_+_4175934 | 1.11 |
ENSMUST00000169055.10
ENSMUST00000135257.11 ENSMUST00000138593.10 ENSMUST00000140267.10 ENSMUST00000137579.6 ENSMUST00000139987.10 ENSMUST00000150627.11 ENSMUST00000151401.11 ENSMUST00000153654.11 |
Tmem134
|
transmembrane protein 134 |
chr19_+_27194757 | 1.11 |
ENSMUST00000047645.13
ENSMUST00000167487.8 |
Vldlr
|
very low density lipoprotein receptor |
chr4_+_155924132 | 1.11 |
ENSMUST00000141883.8
|
Mxra8
|
matrix-remodelling associated 8 |
chr17_+_32904601 | 1.11 |
ENSMUST00000168171.8
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr17_+_32904629 | 1.10 |
ENSMUST00000008801.7
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr5_+_125080504 | 1.09 |
ENSMUST00000197746.2
|
Rflna
|
refilin A |
chr1_+_58752415 | 1.08 |
ENSMUST00000114309.8
ENSMUST00000069333.8 |
Cflar
|
CASP8 and FADD-like apoptosis regulator |
chr4_+_41633286 | 1.07 |
ENSMUST00000119127.2
|
Dnai1
|
dynein axonemal intermediate chain 1 |
chr14_+_75368532 | 1.06 |
ENSMUST00000143539.8
ENSMUST00000134114.8 |
Lcp1
|
lymphocyte cytosolic protein 1 |
chr6_-_128101275 | 1.05 |
ENSMUST00000127105.8
|
Tspan9
|
tetraspanin 9 |
chr9_+_106247943 | 1.05 |
ENSMUST00000173748.2
|
Dusp7
|
dual specificity phosphatase 7 |
chr16_+_13572409 | 1.05 |
ENSMUST00000239037.2
|
A930007A09Rik
|
RIKEN cDNA A930007A09 gene |
chr12_+_112611069 | 1.05 |
ENSMUST00000021728.12
|
Siva1
|
SIVA1, apoptosis-inducing factor |
chr17_-_35081129 | 1.04 |
ENSMUST00000154526.8
|
Cfb
|
complement factor B |
chr10_-_61814852 | 1.04 |
ENSMUST00000105453.8
ENSMUST00000105452.9 ENSMUST00000105454.3 |
Col13a1
|
collagen, type XIII, alpha 1 |
chrX_+_100298134 | 1.04 |
ENSMUST00000062000.6
|
Foxo4
|
forkhead box O4 |
chr6_+_29319132 | 1.03 |
ENSMUST00000090487.12
ENSMUST00000164560.8 |
Fam71f1
|
family with sequence similarity 71, member F1 |
chr1_-_119924920 | 1.03 |
ENSMUST00000174370.8
ENSMUST00000174458.2 |
Cfap221
|
cilia and flagella associated protein 221 |
chr5_+_91039092 | 1.02 |
ENSMUST00000031327.9
|
Cxcl1
|
chemokine (C-X-C motif) ligand 1 |
chr18_+_82929451 | 1.02 |
ENSMUST00000235902.2
|
Zfp516
|
zinc finger protein 516 |
chr19_-_23425757 | 1.02 |
ENSMUST00000036069.8
|
Mamdc2
|
MAM domain containing 2 |
chr9_+_107456086 | 1.01 |
ENSMUST00000149638.8
ENSMUST00000139274.8 ENSMUST00000130053.8 ENSMUST00000122985.8 ENSMUST00000127380.8 ENSMUST00000139581.2 |
Naa80
|
N(alpha)-acetyltransferase 80, NatH catalytic subunit |
chr13_+_93810911 | 1.01 |
ENSMUST00000048001.8
|
Dmgdh
|
dimethylglycine dehydrogenase precursor |
chr3_+_116356592 | 1.01 |
ENSMUST00000029573.8
|
Lrrc39
|
leucine rich repeat containing 39 |
chr14_-_100522101 | 1.01 |
ENSMUST00000228216.2
|
Klf12
|
Kruppel-like factor 12 |
chr11_-_114851243 | 1.01 |
ENSMUST00000092466.13
ENSMUST00000061637.4 |
Cd300c
|
CD300C molecule |
chr17_-_29768586 | 1.01 |
ENSMUST00000234305.2
ENSMUST00000234648.2 ENSMUST00000234979.2 |
Gm17657
Tmem217
|
predicted gene, 17657 transmembrane protein 217 |
chr15_-_78449172 | 0.99 |
ENSMUST00000230952.2
|
Rac2
|
Rac family small GTPase 2 |
chr13_-_41233104 | 0.99 |
ENSMUST00000070193.14
ENSMUST00000165087.8 |
Mak
|
male germ cell-associated kinase |
chr13_-_41233014 | 0.97 |
ENSMUST00000224423.2
|
Mak
|
male germ cell-associated kinase |
chr11_-_70590923 | 0.97 |
ENSMUST00000108543.4
ENSMUST00000108542.8 ENSMUST00000108541.9 ENSMUST00000126114.9 ENSMUST00000073625.8 |
Inca1
|
inhibitor of CDK, cyclin A1 interacting protein 1 |
chr16_+_62674661 | 0.97 |
ENSMUST00000023629.9
|
Pros1
|
protein S (alpha) |
chr12_-_81014849 | 0.97 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr11_-_100302700 | 0.97 |
ENSMUST00000141840.2
|
P3h4
|
prolyl 3-hydroxylase family member 4 (non-enzymatic) |
chr5_-_33375509 | 0.96 |
ENSMUST00000201475.2
|
Spon2
|
spondin 2, extracellular matrix protein |
chr1_-_36578439 | 0.96 |
ENSMUST00000191849.6
|
Gm42417
|
predicted gene, 42417 |
chr4_+_130643260 | 0.95 |
ENSMUST00000030316.7
|
Laptm5
|
lysosomal-associated protein transmembrane 5 |
chr6_-_129600812 | 0.95 |
ENSMUST00000168919.8
|
Klrk1
|
killer cell lectin-like receptor subfamily K, member 1 |
chr18_+_46983105 | 0.94 |
ENSMUST00000025358.4
ENSMUST00000234519.2 |
Lvrn
|
laeverin |
chr8_+_120729459 | 0.94 |
ENSMUST00000108972.4
|
Crispld2
|
cysteine-rich secretory protein LCCL domain containing 2 |
chr9_-_49397508 | 0.94 |
ENSMUST00000055096.5
|
Ttc12
|
tetratricopeptide repeat domain 12 |
chr4_-_141660390 | 0.93 |
ENSMUST00000036701.8
|
Fhad1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
chr19_+_56710570 | 0.93 |
ENSMUST00000038949.6
|
Adrb1
|
adrenergic receptor, beta 1 |
chr4_-_107780716 | 0.92 |
ENSMUST00000106719.8
ENSMUST00000106720.9 ENSMUST00000131644.2 ENSMUST00000030345.15 |
Cpt2
|
carnitine palmitoyltransferase 2 |
chr2_-_164427367 | 0.92 |
ENSMUST00000109342.2
|
Wfdc6a
|
WAP four-disulfide core domain 6A |
chr2_-_45002902 | 0.91 |
ENSMUST00000076836.13
ENSMUST00000176732.8 ENSMUST00000200844.4 |
Zeb2
|
zinc finger E-box binding homeobox 2 |
chr1_+_180878797 | 0.91 |
ENSMUST00000036819.7
|
9130409I23Rik
|
RIKEN cDNA 9130409I23 gene |
chr6_+_37507108 | 0.90 |
ENSMUST00000040987.11
|
Akr1d1
|
aldo-keto reductase family 1, member D1 |
chr12_-_112893382 | 0.90 |
ENSMUST00000075827.5
|
Jag2
|
jagged 2 |
chr18_-_79152504 | 0.89 |
ENSMUST00000025430.11
|
Setbp1
|
SET binding protein 1 |
chr6_-_129600798 | 0.89 |
ENSMUST00000095412.10
|
Klrk1
|
killer cell lectin-like receptor subfamily K, member 1 |
chr6_+_48715971 | 0.89 |
ENSMUST00000054368.7
ENSMUST00000140054.3 ENSMUST00000204168.2 ENSMUST00000204408.2 |
Gimap1
Gm28053
|
GTPase, IMAP family member 1 predicted gene, 28053 |
chr10_-_63039709 | 0.89 |
ENSMUST00000095580.3
|
Mypn
|
myopalladin |
chr6_+_141194886 | 0.89 |
ENSMUST00000043259.10
|
Pde3a
|
phosphodiesterase 3A, cGMP inhibited |
chr4_-_82423511 | 0.88 |
ENSMUST00000050872.15
ENSMUST00000064770.9 |
Nfib
|
nuclear factor I/B |
chr6_+_145561483 | 0.88 |
ENSMUST00000087445.7
|
Tuba3b
|
tubulin, alpha 3B |
chr11_-_94390788 | 0.88 |
ENSMUST00000127305.2
|
Epn3
|
epsin 3 |
chr6_+_48624295 | 0.88 |
ENSMUST00000078223.6
ENSMUST00000203509.2 |
Gimap8
|
GTPase, IMAP family member 8 |
chr4_+_99544536 | 0.87 |
ENSMUST00000087285.5
|
Foxd3
|
forkhead box D3 |
chr18_+_84869883 | 0.86 |
ENSMUST00000163083.2
|
Cyb5a
|
cytochrome b5 type A (microsomal) |
chr11_+_98828495 | 0.86 |
ENSMUST00000107475.9
ENSMUST00000068133.10 |
Rara
|
retinoic acid receptor, alpha |
chr17_-_29768531 | 0.85 |
ENSMUST00000168339.3
ENSMUST00000114683.10 ENSMUST00000234620.2 |
Tmem217
|
transmembrane protein 217 |
chrX_-_47123719 | 0.85 |
ENSMUST00000039026.8
|
Apln
|
apelin |
chr14_+_69846517 | 0.85 |
ENSMUST00000022660.14
|
Loxl2
|
lysyl oxidase-like 2 |
chr3_-_96501443 | 0.84 |
ENSMUST00000145001.2
ENSMUST00000091924.10 |
Polr3gl
|
polymerase (RNA) III (DNA directed) polypeptide G like |
chr8_+_93400916 | 0.84 |
ENSMUST00000034185.13
|
Irx6
|
Iroquois homeobox 6 |
chr4_+_52964547 | 0.84 |
ENSMUST00000215010.2
ENSMUST00000215127.2 |
Olfr270
|
olfactory receptor 270 |
chr5_-_114131934 | 0.84 |
ENSMUST00000159592.8
|
Ssh1
|
slingshot protein phosphatase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.6 | GO:1902617 | response to fluoride(GO:1902617) |
1.3 | 4.0 | GO:0042694 | muscle cell fate specification(GO:0042694) |
1.3 | 7.8 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
1.1 | 3.3 | GO:0006740 | NADPH regeneration(GO:0006740) |
1.0 | 4.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
1.0 | 3.0 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
0.8 | 2.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.8 | 2.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 3.0 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.7 | 3.3 | GO:2001274 | positive regulation of fat cell proliferation(GO:0070346) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.7 | 2.0 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.6 | 1.9 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.6 | 1.8 | GO:0030887 | positive regulation of myeloid dendritic cell activation(GO:0030887) |
0.6 | 3.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
0.5 | 1.4 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.5 | 0.9 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.5 | 1.4 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.5 | 4.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 2.3 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.4 | 2.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 3.0 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.4 | 3.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.4 | 1.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.4 | 2.4 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.4 | 1.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.4 | 7.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.4 | 1.6 | GO:0032752 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) cellular response to molecule of fungal origin(GO:0071226) |
0.4 | 1.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.4 | 2.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.3 | 1.0 | GO:0070949 | neutrophil mediated killing of fungus(GO:0070947) regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 1.3 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 1.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.3 | 2.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.9 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.3 | 3.9 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.3 | 1.4 | GO:0010958 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.3 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 0.8 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.3 | 0.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 0.8 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.3 | 1.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 1.1 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.3 | 0.8 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.3 | 1.1 | GO:1903944 | skeletal muscle atrophy(GO:0014732) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.3 | 2.9 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 7.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.3 | 0.8 | GO:0060156 | vascular transport(GO:0010232) milk ejection(GO:0060156) |
0.3 | 2.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 2.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 1.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.9 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.2 | 0.7 | GO:0071640 | macrophage inflammatory protein-1 alpha production(GO:0071608) regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
0.2 | 0.9 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 | 4.5 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 3.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 3.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 6.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 1.6 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 0.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 1.4 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.2 | 2.0 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.2 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 1.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 1.1 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.7 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.2 | 1.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 1.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 1.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.2 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.8 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.2 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.4 | GO:1902867 | negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.1 | 0.6 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 1.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 1.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 1.0 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 2.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.4 | GO:0015734 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
0.1 | 3.3 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 1.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 2.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.6 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 4.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
0.1 | 1.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 3.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 1.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.9 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 1.6 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 2.2 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.3 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 1.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 1.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 1.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 1.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 2.5 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.9 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.2 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.1 | 2.7 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.1 | 0.4 | GO:0035120 | post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
0.1 | 0.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 1.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.2 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 1.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 9.2 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 2.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.1 | GO:0051085 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.4 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.1 | 0.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 1.6 | GO:0042092 | type 2 immune response(GO:0042092) |
0.1 | 0.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.2 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.7 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 1.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.8 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 1.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 1.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 3.0 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.5 | GO:0035878 | nail development(GO:0035878) |
0.0 | 1.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 1.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 1.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 1.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 1.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 2.2 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 2.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 1.2 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 1.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 1.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0061107 | negative regulation of plasminogen activation(GO:0010757) seminal vesicle development(GO:0061107) |
0.0 | 0.3 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.0 | 1.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 2.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.7 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:1902262 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 0.7 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.4 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.6 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.3 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 2.0 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 0.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:1902163 | negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902163) |
0.0 | 0.2 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.1 | GO:0035561 | regulation of chromatin binding(GO:0035561) negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.0 | 0.1 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.7 | 6.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.7 | 2.0 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.5 | 1.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 7.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 6.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.4 | 7.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 4.5 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 4.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 2.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 3.9 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 2.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 2.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 2.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 1.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.4 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.1 | 1.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 1.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 1.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.7 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 1.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.9 | GO:0043034 | costamere(GO:0043034) |
0.0 | 1.1 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 4.4 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 9.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 5.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 5.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 1.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 5.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 1.4 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 11.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 1.5 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 6.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 3.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 3.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 3.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.7 | 6.6 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
1.4 | 4.2 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
1.3 | 7.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.7 | 2.2 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.6 | 7.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 1.8 | GO:0032394 | MHC class Ib receptor activity(GO:0032394) |
0.6 | 1.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 1.6 | GO:0008127 | quercetin 2,3-dioxygenase activity(GO:0008127) |
0.5 | 2.0 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.5 | 1.4 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.5 | 1.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 3.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 1.2 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 3.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 2.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.4 | 3.0 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 2.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.4 | 1.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.4 | 1.4 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 2.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.3 | 2.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 1.9 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
0.3 | 1.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 0.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.3 | 1.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.9 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.3 | 0.8 | GO:0001571 | non-tyrosine kinase fibroblast growth factor receptor activity(GO:0001571) |
0.3 | 2.4 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
0.3 | 0.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.3 | 0.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 1.3 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.3 | 1.0 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 1.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 0.9 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.7 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 2.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 2.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.2 | 5.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 1.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 2.3 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 1.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.2 | 0.9 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.2 | 1.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 3.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 0.9 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.4 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.1 | 1.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.4 | GO:0005369 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.1 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 3.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 3.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.7 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 1.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.5 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 2.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 2.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 1.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 3.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 1.5 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 3.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.3 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.1 | 1.2 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 3.3 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 4.3 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.0 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 1.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 1.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.7 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 1.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 2.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 1.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 1.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 2.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 1.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 4.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 1.0 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 9.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 1.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 3.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 1.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 1.5 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 2.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.3 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 7.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 5.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 2.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 7.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 4.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 9.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 4.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 2.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 6.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 8.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 2.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 2.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 7.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 3.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.3 | 7.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 3.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 4.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 3.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 3.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 7.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 5.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 3.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 4.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 2.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 1.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 2.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 1.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.6 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 1.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 2.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |